Praluent 150 mg

Praluent 150 mg is a subcutaneous solution containing alirocumab, used for managing high cholesterol levels. This medication helps reduce LDL cholesterol, supporting cardiovascular health.

Praluent 150 mg is primarily used to lower LDL cholesterol in adults with primary hyperlipidemia. It is often prescribed alongside diet and exercise to manage cholesterol levels. This medication is also used in adults with heterozygous familial hypercholesterolemia, a genetic condition that causes high cholesterol.

Common effects of Praluent 150 mg may include injection site reactions, such as redness, swelling, or itching. Some users may experience flu-like symptoms, including headache, fatigue, or muscle pain. These effects are generally mild and temporary.

Praluent 150 mg should be used with caution in individuals with a history of allergic reactions to alirocumab or similar medications. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your healthcare provider about any other medications you are taking.

Praluent 150 mg may interact with other medications, including those that affect the immune system or blood-thinning drugs. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should be moderated while using this medication.